The Impact of Uremic Toxins on Alzheimer's Disease
METADATA ONLY
Loading...
Author / Producer
Date
2022-02
Publication Type
Review Article
ETH Bibliography
yes
Citations
Altmetric
METADATA ONLY
Data
Rights / License
Abstract
Alzheimer's disease (AD) is the most common type of dementia, pathologically characterized by the accumulation of senile plaques and neurofibrillary tangles. Chronic kidney disease (CKD) is highly prevalent in the elderly population closely associated with the occurrence of dementia. Recent epidemiological and experimental studies suggest a potential association of CKD with AD. Both diseases share a panel of identical risk factors, such as type 2 diabetes and hypertension. However, the relationship between CKD and AD is unclear. Lower clearance of a panel of uremic toxin including cys-tatin-C, guanidine, and adiponectin due to CKD is implied to contribute to AD pathogenesis. In this re-view, we summarize the current evidence from epidemiological, experimental, and clinical studies on the potential contribution of uremic toxins to AD pathogenesis. We describe outstanding questions and propose an outlook on the link between uremic toxins and AD.
Permanent link
Publication status
published
Editor
Book title
Journal / series
Volume
19 (2)
Pages / Article No.
104 - 118
Publisher
Bentham
Event
Edition / version
Methods
Software
Geographic location
Date collected
Date created
Subject
Alzheimer's disease; Amyloid; Chronic kidney disease; Inflammation; Tau; Uremic toxins